Feedback / Questions
IMU-935 - Immunic
IMU-935: Initiation of PART B of P1 trial in healthy volunteers in Q3 2020
(Immunic Therapeutics)
-
May 28, 2020 -
R&D Day: Initiation of PART C of P1 trial for moderate-to-severe psoriasis in H2 2020
Trial status
•
Psoriasis
http://ir.imux.com/events-and-presentations?item=36
May 28, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious